HER2-LOW HORMONE RECEPTOR POSITIVE BREAST CANCER

Clinical trials for HER2-LOW HORMONE RECEPTOR POSITIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HER2-LOW HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for HER2-LOW HORMONE RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill combo aims to boost cancer fight in tough cases

Disease control Recruiting now

This study is testing whether adding two new oral drugs, AMXT 1501 and DFMO, to standard cancer treatments can help control advanced breast cancer or melanoma that has continued to grow despite prior therapies. The trial will first find a safe dose and then see how well the combi…

Matched conditions: HER2-LOW HORMONE RECEPTOR POSITIVE BREAST CANCER

Phase: PHASE1, PHASE2 • Sponsor: Aminex Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

HER2-LOW HORMONE RECEPTOR POSITIVE BREAST CANCER

Get alerted when new HER2-LOW HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear

New pill combo aims to boost cancer fight in tough cases